GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Devonian Health Group Inc (TSXV:GSD) » Definitions » Altman Z-Score

Devonian Health Group (TSXV:GSD) Altman Z-Score : 0.66 (As of Apr. 02, 2025)


View and export this data going back to 2014. Start your Free Trial

What is Devonian Health Group Altman Z-Score?

The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.

Warning Sign:

Altman Z-score of 0.75 is in distress zone. This implies bankruptcy possibility in the next two years.

Devonian Health Group has a Altman Z-Score of 0.66, indicating it is in Distress Zones. This implies bankrupcy possibility in the next two years.

The zones of discrimination were as such:

When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.

The historical rank and industry rank for Devonian Health Group's Altman Z-Score or its related term are showing as below:

TSXV:GSD' s Altman Z-Score Range Over the Past 10 Years
Min: -5.13   Med: 1.19   Max: 8.49
Current: 0.75

During the past 11 years, Devonian Health Group's highest Altman Z-Score was 8.49. The lowest was -5.13. And the median was 1.19.


Devonian Health Group Altman Z-Score Historical Data

The historical data trend for Devonian Health Group's Altman Z-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Devonian Health Group Altman Z-Score Chart

Devonian Health Group Annual Data
Trend Jun15 Jun16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23 Jul24
Altman Z-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.72 1.57 5.41 2.46 0.37

Devonian Health Group Quarterly Data
Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24
Altman Z-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.57 0.60 0.16 0.37 0.21

Competitive Comparison of Devonian Health Group's Altman Z-Score

For the Biotechnology subindustry, Devonian Health Group's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Devonian Health Group's Altman Z-Score Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Devonian Health Group's Altman Z-Score distribution charts can be found below:

* The bar in red indicates where Devonian Health Group's Altman Z-Score falls into.


;
;

Devonian Health Group Altman Z-Score Calculation

Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

Devonian Health Group's Altman Z-Score for today is calculated with this formula:

Z=1.2*X1+1.4*X2+3.3*X3+0.6*X4+1.0*X5
=1.2*0.0722+1.4*-0.8102+3.3*-0.0165+0.6*1.8091+1.0*0.6717
=0.66

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.

Trailing Twelve Months (TTM) ended in Oct. 2024:
Total Assets was C$33.34 Mil.
Total Current Assets was C$21.14 Mil.
Total Current Liabilities was C$18.73 Mil.
Retained Earnings was C$-27.01 Mil.
Pre-Tax Income was -0.362 + 1.081 + -0.374 + -1.21 = C$-0.87 Mil.
Interest Expense was -0.09 + -0.069 + -0.089 + -0.067 = C$-0.32 Mil.
Revenue was 5.851 + 9.14 + 5.126 + 2.277 = C$22.39 Mil.
Market Cap (Today) was C$34.09 Mil.
Total Liabilities was C$18.84 Mil.

* Note that for stock reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data.

X1=Working Capital/Total Assets
=(Total Current Assets - Total Current Liabilities)/Total Assets
=(21.138 - 18.73)/33.34
=0.0722

X2=Retained Earnings/Total Assets
=-27.013/33.34
=-0.8102

X3=Earnings Before Interest and Taxes/Total Assets
=(Pre-Tax Income - Interest Expense)/Total Assets
=(-0.865 - -0.315)/33.34
=-0.0165

X4=Market Value Equity/Book Value of Total Liabilities
=Market Cap/Total Liabilities
=34.091/18.844
=1.8091

X5=Revenue/Total Assets
=22.394/33.34
=0.6717

The zones of discrimination were as such:

Distress Zones - 1.81 < Grey Zones < 2.99 - Safe Zones

Devonian Health Group has a Altman Z-Score of 0.66 indicating it is in Distress Zones.

Study by Altman found that companies that are in Distress Zone have more than 80% of chances of bankruptcy in two years.


Devonian Health Group  (TSXV:GSD) Altman Z-Score Explanation

X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.

X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.

X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.

X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.

X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.

Read more about Altman Z-Score and the original research.


Be Aware

Altman Z-Score does not apply to financial companies.


Devonian Health Group Altman Z-Score Related Terms

Thank you for viewing the detailed overview of Devonian Health Group's Altman Z-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Devonian Health Group Business Description

Traded in Other Exchanges
Address
360, Rue des Entrepreneurs, Montmagny, QC, CAN, G5V 4T1
Devonian Health Group Inc is operating in the pharmaceutical sector. It is engaged in the development and distribution of botanical drugs. The group is also involved in the development of value-added products for dermo-cosmetics. It has established a research effort focused on the anticipation of new solutions in the medical sector as well as in the cosmetic sector. The company's technology platform, The Supra Molecular Complex Extraction and Stabilization Technology provides a process of extraction, purification, stabilization, and conditioning of molecular complexes, as active botanical ingredients, from plants and algae. Its product portfolio includes pharmaceuticals like Thykamine, Pantoprazole, and Cleo-35; and cosmeceutical products like R-Spinasome and Purgenesis.

Devonian Health Group Headlines

No Headlines